![]() |
2′-deoxycytidine |
---|---|
Trade Name | |
Orphan Indication | As a host-protective agent in the treatment of acute myelogenous leukemia |
USA Market Approval | USA |
USA Designation Date | 1996-09-09 00:00:00 |
Sponsor | Grant, Steven M.D.;Massey Cancer Center, VCU, P.O. Box 980230;Richmond, Virginia, 23298 |